ARTICLE | Company News
NeuroSearch, Astellas deal
March 9, 2009 7:00 AM UTC
Astellas returned to NeuroSearch exclusive, worldwide rights excluding North America, EU, Norway and Switzerland to ACR16 for schizophrenia, ending its 2005 deal with the biotech. Astellas made the d...